Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug-Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir.
about
Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 InfectionPharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal ImpairmentAnti-hepatitis C virus drugs and kidneyPharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIVOptimum combination therapy regimens for HIV/HCV infection.Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.Sofosbuvir/Velpatasvir: The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C.Pharmacokinetic drug evaluation of velpatasvir plus sofosbuvir for the treatment of hepatitis C virus infection.Developing therapies to treat hepatitis C infection in post-liver transplant recipients.Drug interactions in HIV-infected patients treated for hepatitis C.Treatment of hepatitis C with new fixed dose combinations.
P2860
Q26746563-85F5739F-1A9A-4590-9F89-7857CD5A8419Q26751452-2A9BE5EE-9331-4622-A925-15AFE73156FBQ28070279-AB9C5031-1A9A-4A2D-85DA-7222C2C4A50BQ37055231-77E2BF72-BC91-4A6E-ADAB-3317C415B48DQ38715477-B0A62155-24FB-4A5A-B622-48ABACC3B923Q38927205-E5FD9DB8-3DAD-4B5A-9B1C-2D6414C6A2B2Q38949900-B1678C4F-314A-4EDC-915C-A4F766D635EAQ38976791-31428F18-8CB6-4697-A6A0-214C85D5419FQ39055696-A634A952-53BC-403C-84BC-142B1E6C9836Q40143109-B72BA9F0-0190-42BD-A792-3A8E3A6ECF02Q40148071-B59F757E-5F50-4EF1-AC2B-3EB922228333
P2860
Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug-Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use of Multiple Probes to Asse ...... CV NS5A Inhibitor Velpatasvir.
@en
type
label
Use of Multiple Probes to Asse ...... CV NS5A Inhibitor Velpatasvir.
@en
prefLabel
Use of Multiple Probes to Asse ...... CV NS5A Inhibitor Velpatasvir.
@en
P2093
P2860
P1476
Use of Multiple Probes to Asse ...... CV NS5A Inhibitor Velpatasvir.
@en
P2093
Anita Mathias
Brian P Kearney
Cheng Yong Yang
Diana Brainard
Erik Mogalian
John McNally
Lisa Moorehead
Polina German
P2860
P2888
P304
P356
10.1007/S40262-015-0334-7
P577
2015-10-30T00:00:00Z
P6179
1036958058